Clin2
NCT07539415Likely a fitRecruiting

Safety and effectiveness study of new injection in healthy adults

Obesity & OverweightType 2 Diabetes

Part of Hormones & metabolism clinical trials.

This study tests a new experimental injection in healthy volunteers to see if it's safe and how well the body absorbs it. Researchers will compare it with other similar treatments to understand how it works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
72 people
Ages
19 years to 64 years
Study type
Interventional

Who can take part

  • Age between 19 and 65 years old
  • Weight between 110–220 lbs (50–100 kg) and BMI between 20–29.9
  • No serious medical conditions like heart disease, diabetes, liver problems, or kidney disease
  • Not pregnant, breastfeeding, or planning to become pregnant during the study
  • No history of severe allergies to GLP-1 drugs or similar medications
  • No history of pancreatitis, thyroid cancer, or family history of MEN2 syndrome

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06974487Not yet recruiting· Phase 1
Weight management study for overweight adults

This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.

Beijing
NCT06859853Recruiting· Phase 1
MWN109 injection safety study in healthy volunteers

This trial tests an investigational injection called MWN109 to see if it is safe and how the body processes it. It is for healthy adults only, and the results will help decide if the drug should be tested in people with medical conditions.

Melbourne, Victoria
NCT07716241Not yet recruiting· Phase 1
Study of an investigational injection for weight management in healthy or overweight adults

This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.

Hefei
NCT07824804Not yet recruiting· Phase 1
Safety study of an injection for weight management

This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.

Kunming, Yunnan
NCT07779980Not yet recruiting· Phase 1
Study of an investigational injection for overweight and obesity

This study tests a new investigational injection called MWN110 in people who are overweight or have obesity. The goal is to see if the drug is safe and how it affects the body, which may help with weight management.

Kunming, Yunnan
NCT07873645Not yet recruiting· Phase 1
Testing an experimental injection for weight management

This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.